---
id: multi-omics-integration
title: Multi-Omics Integration
domain: biology
course: genomics-and-bioinformatics
prerequisites:
- id: differential-gene-expression
  type: hard
- id: variant-calling-and-gwas
  type: hard
- id: epigenomics-chip-seq-atac-seq
  type: soft
- id: proteomics-data-analysis
  type: soft
- id: metabolomics
  type: soft
- id: systems-biology-data-integration
  type: soft
builds-toward: []
tags:
- multi-omics
- data-integration
- MOFA
- single-cell-multiome
- causal-inference
- precision-medicine
stage: expert
status: validated
---
# Multi-Omics Integration

## Core Idea
Multi-omics integration combines data from multiple molecular layers — genomics, transcriptomics, epigenomics, proteomics, metabolomics — to build comprehensive models of biological systems. No single omics layer captures the full picture: DNA variants explain predisposition, chromatin state explains regulatory potential, transcripts show regulatory activity, proteins show functional capacity, and metabolites show biochemical output. Integration methods range from simple overlap analysis to sophisticated statistical frameworks (MOFA, DIABLO, network-based methods) that identify shared and layer-specific sources of variation. Single-cell multiome technologies now measure multiple modalities (RNA + ATAC, RNA + protein) in the same cell, enabling within-cell integration.

## How It's Best Learned
Take matched RNA-seq and ATAC-seq datasets from the same samples and use MOFA2 to identify shared and modality-specific factors of variation. Examine whether the top shared factor corresponds to the biological condition of interest (e.g., disease vs. healthy). Then explore single-cell multiome data (10x Multiome) where RNA and ATAC are measured in the same cells, and link enhancer accessibility to gene expression at single-cell resolution.

## Common Misconceptions
- Multi-omics integration is not simply overlapping significant results from each layer — sophisticated methods are needed to account for different scales, distributions, noise levels, and dimensionalities across data types.
- More omics layers do not automatically produce better results — poorly designed experiments, batch effects, or mismatched samples can make integration counterproductive.

## Questions

```yaml
- question: "Why is multi-omics integration more informative than analyzing each omics layer independently?"
  type: multiple-choice
  options: ["Multi-omics integration is faster computationally", "Integration reveals cross-layer relationships — such as how a genetic variant affects chromatin accessibility, gene expression, and metabolite levels — that single-layer analysis cannot detect", "Each omics layer measures the same thing with different accuracy", "Multi-omics data always has fewer missing values"]
  answer: 1
  explanation: "Biological causation flows across molecular layers: a genetic variant may alter transcription factor binding (epigenomics), which changes gene expression (transcriptomics), which alters protein levels (proteomics), which changes metabolite flux (metabolomics). Analyzing each layer independently identifies associations within that layer but misses the causal chain connecting them. Integration traces these cross-layer connections, identifying the molecular mechanisms that link genotype to phenotype and revealing regulatory relationships invisible to any single modality."

- question: "Measuring RNA and chromatin accessibility in the same single cell (multiome) provides no advantage over measuring them in separate cells from the same sample."
  type: true-false
  answer: false
  explanation: "Within-cell multiome measurement enables direct correlation of epigenomic state with transcriptional output at the single-cell level. In separate experiments, the link between a cell's chromatin accessibility and its gene expression must be inferred statistically by matching similar cells across modalities — an inherently noisy process that assumes cell states are consistent between experiments. Multiome data from the same cell eliminates this matching problem, enabling precise quantification of how enhancer accessibility drives gene expression in individual cells and identification of regulatory relationships that are obscured in aggregate or cross-modality analyses."

- question: "Describe the main challenges of integrating data from multiple omics platforms."
  type: short-answer
  answer: "Key challenges include: (1) Different data scales and distributions — RNA-seq counts, mass spec intensities, and methylation percentages have fundamentally different statistical properties requiring appropriate normalization. (2) Missing data — not all features are measured across all platforms, and within platforms, dropout and detection limits create gaps. (3) Different feature spaces — genomics operates on variants, transcriptomics on genes, proteomics on proteins, and metabolomics on metabolites, requiring mapping between feature types. (4) Batch effects — technical variation between platforms and experiments can overwhelm biological signal if not properly corrected. (5) Sample matching — ensuring that measurements from different platforms truly represent the same biological state, especially when samples cannot be processed simultaneously."
  explanation: "These challenges explain why multi-omics integration requires specialized statistical methods rather than simple concatenation. Methods like MOFA (Multi-Omics Factor Analysis) decompose the variation across layers into latent factors, handling different data types and missing values within a unified probabilistic framework."
```

## Explainer

Each omics technology provides a partial view of cellular biology: genomics shows the static blueprint, epigenomics shows the regulatory switches, transcriptomics shows which genes are active, proteomics shows the functional machinery, and metabolomics shows the biochemical output. Multi-omics integration aims to combine these partial views into a comprehensive picture — connecting genetic variation to molecular mechanisms to phenotypic outcomes.

The simplest integration approach is **sequential analysis**: perform GWAS to find disease-associated variants, check whether they fall in regulatory elements (using epigenomic maps), test whether they affect gene expression (using eQTL data), and trace the downstream effects on protein and metabolite levels. This hypothesis-driven approach is powerful when the biological question is specific (what does this variant do?) but cannot discover unexpected cross-layer relationships. **Concatenation-based methods** stack all omics features into a single matrix and apply standard multivariate analysis (PCA, clustering, classification), but this ignores the fundamentally different statistical properties of each data type.

**Factor-based methods** like MOFA (Multi-Omics Factor Analysis) and DIABLO provide a more principled framework. They decompose the variation across all omics layers into a small number of latent factors, identifying which factors are shared across layers (reflecting coordinated biological processes) and which are specific to individual layers (reflecting modality-specific technical or biological variation). A shared factor that separates disease from healthy samples across transcriptomics, proteomics, and metabolomics simultaneously is strong evidence for a coordinated biological program. The factor loadings identify which specific genes, proteins, and metabolites drive the pattern.

**Single-cell multiome** technologies represent the cutting edge. 10x Genomics Multiome simultaneously measures RNA expression and chromatin accessibility (ATAC) in the same cell. CITE-seq measures RNA and surface protein levels in the same cell. These paired measurements within individual cells eliminate the need for computational cross-modality matching and enable direct quantification of regulatory relationships: how does the accessibility of an enhancer in cell A relate to the expression of its target gene in that same cell? Methods like ArchR and Signac analyze multiome data by linking peaks to genes, identifying cell-type-specific regulatory elements, and building regulatory networks grounded in matched single-cell measurements. As these technologies mature — adding more modalities, more cells, and spatial resolution — multi-omics integration will increasingly move from population-level statistical associations to mechanistic single-cell models of gene regulation.
